EUVIMED · CrossrefZeitschrift
PharmacoEconomics
ISSN 1170-7690 · Springer Science and Business Media LLC
Neueste Artikel
The Accumulation of Healthcare, Benefit and Social Care Costs of Depression Before and After Diagnosis: A Six-Year Observational Cohort Study
Economic Evaluation Models of Specialty Disease-Modifying Anti-rheumatic Drugs After Failure of Conventional Therapies: A Systematic Review
Response to Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”
Comment on “Valuation of EQ-5D-5L Health States in Poland: The First EQ-VT-Based Study in Central and Eastern Europe”
Constructing a US Value Set for Child Health States: The PedsUtil Scoring System
A Systematic Literature Review on the Economic Burden of Sjögren’s Disease
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance
Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings
The Economic Burden of Duchenne Muscular Dystrophy: A Systematic Review
Estimating the Value of Combination Vaccines: A Methodological Framework
The Cost Effectiveness of Upgrading Cochlear Implant Sound Processors in Australia: A Novel Application of Individual-Level Microsimulation Models
A Systematic Review of the Economic Burden of Prostate Cancer: Direct and Indirect Cost Perspectives
Microsimulation Modeling for Health Decision Sciences Using C++: A Tutorial
Comparing the Influence of Heterogeneity on Model Outcomes in Individual-Level and Cohort Simulations: An Exploratory Simulation Study
Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes
Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease
Cost-Effectiveness Analysis of Aztreonam-Avibactam (ATM-AVI) Versus Colistin + Meropenem (COL + MER) for the Treatment of Infections Caused by Metallo-β-Lactamase (MBL)-Producing Enterobacterales in Italy
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Scoping Review of Productivity-Adjusted Life Years (PALYs): Methods, Applications and Policy Implications
Bayesian Cost-Effectiveness Analysis Using Individual-Level Data is Sensitive to the Choice of Uniform Priors on the Standard Deviations for Costs in Log-Normal Models
Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention
The Burden of Informal Caregiving for Adults with Musculoskeletal Conditions: A Systematic Review
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden
Key Considerations for Assessing Real-World Comparative Effectiveness in the Context of the Drug Price Negotiation Program: A Case Study of Pembrolizumab
Under-reporting of Validation Efforts for Health Economic Models Persists Despite the Availability of Validation Tools: A Systematic Review
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review
Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada
How do Health State Values Differ When Respondents Consider Adults Versus Children Living in Those States? A Systematic Review
Do the Age of Children and Parental Status Matter in Valuing the Child Health Utility 9D (CHU9D)?
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection
Jahrgänge
2026 · 1102025 · 1102024 · 1162023 · 1062022 · 1232021 · 1142020 · 1192019 · 1332018 · 1292017 · 1172016 · 1152015 · 1062014 · 1112013 · 1012012 · 952011 · 882010 · 1142009 · 922008 · 862007 · 862006 · 1402005 · 1142004 · 1252003 · 1072002 · 1032001 · 1052000 · 1131999 · 1311998 · 1541997 · 1521996 · 1811995 · 1331994 · 1751993 · 1071992 · 150
EUVIMED